Meropenem and Abacavir drug interactions - a phase IV clinical study of FDA data
Summary:
Drug interactions are reported among people who take Meropenem (meropenem) and Abacavir (abacavir sulfate). Common drug interactions include clostridium test positive among females and sepsis among males.
The phase IV clinical study analyzes what interactions people have when they take Meropenem and Abacavir. It is created by eHealthMe based on reports of 37 people who take the same drugs from the FDA, and is updated regularly.
What is Meropenem?
Meropenem has active ingredients of meropenem. eHealthMe is studying from 33,295 Meropenem users. Check the latest studies of Meropenem.
What is Abacavir?
Abacavir has active ingredients of abacavir sulfate. It is often used in hiv infection. eHealthMe is studying from 8,306 Abacavir users. Check the latest studies of Abacavir.
37 people who take Meropenem and Abacavir together, and have interactions are studied.

What are the common drug interactions of Meropenem and Abacavir, by gender? *:
female:
- Clostridium test positive
- Depression
- Pneumonia
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Aids encephalopathy (malfunction of the brain as a result of hiv infection, variety of cognitive, motor, and behavioural abnormalities)
- Delirium (wild excitement)
- Depressed mood
- Immune reconstitution syndrome (immune recovery syndrome)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Pneumonia fungal
male:
- Sepsis (a severe blood infection that can lead to organ failure and death)
- Abdominal pain
- Facial bones fracture (bone fracture of face)
- Fatigue (feeling of tiredness)
- Febrile neutropenia (fever with reduced white blood cells)
- Headache (pain in head)
- Hepatosplenomegaly (enlargement of both the liver and the spleen)
- Hospitalisation
- Hypertension (high blood pressure)
- Livedo reticularis (a lace-like purplish discoloration of the skin)
What are the common drug interactions of Meropenem and Abacavir, by age (0-1 to 60+)? *:
0-1:
- Respiratory failure (inadequate gas exchange by the respiratory system)
- Staphylococcal sepsis (blood infection by an infection with staphylococcus bacteria)
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Drug resistance (reduction in effectiveness of a drug)
- Dyspnoea (difficult or laboured respiration)
- Hepatosplenomegaly (enlargement of both the liver and the spleen)
- Hypertension (high blood pressure)
- Livedo reticularis (a lace-like purplish discoloration of the skin)
- Oxygen saturation decreased
2-9:
n/a
10-19:
n/a
20-29:
- Cor pulmonale acute (rapid enlargement of the right ventricle of the heart)
- Drug-induced liver injury (diseases of the liver that are caused by physician-prescribed medications)
- Hyponatraemia (abnormally low level of sodium in the blood; associated with dehydration)
- Pneumothorax (the presence of air or gas in the cavity between the lungs and the chest wall, causing collapse of the lung)
- Respiratory distress (difficulty in breathing)
- Seizure (abnormal excessive or synchronous neuronal activity in the brain)
30-39:
- Anaemia (lack of blood)
- Leukopenia (less number of white blood cells in blood)
- Abdominal infection
- Citrobacter infection (infection by citrobacter (bacteria))
- Deep vein thrombosis (blood clot in a major vein that usually develops in the legs and/or pelvis)
- Enterococcal infection
- Pneumonia pseudomonal (pseudomonas pneumonia is an infection caused by the microbe known as pseudomonas aeruginosa)
- Pseudomonas infection (pseudomonas infection is caused by a bacterium, pseudomonas aeruginosa)
- Rash maculo-papular (red area on the skin that is covered with small confluent bumps)
- Respiratory tract infection
40-49:
- Ascites (accumulation of fluid in the abdominal cavity)
- Blood culture positive
- Cholestasis (a condition where bile cannot flow from the liver to the duodenum)
- Drug hypersensitivity
- Granuloma (a small area of inflammation due to tissue injury)
- Haematemesis (vomiting of blood)
- Haemoglobin decreased
- Heart rate increased
- Hepatitis (inflammation of the liver)
- Infection
50-59:
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection)
- Pneumonia aspiration (bronchopneumonia that develops due to the entrance of foreign materials into the bronchial tree)
- Abdominal pain
- Alanine aminotransferase increased
- Aspartate aminotransferase increased
- Blood alkaline phosphatase increased
- Blood bilirubin increased
- Bowel movement irregularity
- Cellulitis (infection under the skin)
- Facial bones fracture (bone fracture of face)
60+:
- Anaemia (lack of blood)
- Cytomegalovirus colitis (an inflammation of the colon from virus)
- Clostridium test positive
- Depression
- Pneumonia
- Aids encephalopathy (malfunction of the brain as a result of hiv infection, variety of cognitive, motor, and behavioural abnormalities)
- Delirium (wild excitement)
- Depressed mood
- Immune reconstitution syndrome (immune recovery syndrome)
- Neutropenia (an abnormally low number of neutrophils)
What are the existing conditions these people have? *
- Tuberculosis (a bacterial infection by mycobacterium tuberculosis): 5 people, 13.51%
- Infection: 5 people, 13.51%
- Cytomegalovirus Infection: 5 people, 13.51%
- Agranulocytosis (a deficiency of granulocytes in the blood, causing increased vulnerability to infection): 5 people, 13.51%
- Primary Effusion Lymphoma (large b-cell cancer): 4 people, 10.81%
- Kaposi's Sarcoma (a tumour caused by human herpes virus): 4 people, 10.81%
- Respiratory Acidosis (respiratory failure or ventilatory failure, causes the ph of blood and other bodily fluids to decrease): 3 people, 8.11%
- Primary Pulmonary Hypertension (primary high blood pressure that affects the arteries in the lungs and the right side of your heart): 3 people, 8.11%
- Pain: 3 people, 8.11%
- Lymphoma (cancer that begins in immune system cells): 3 people, 8.11%
* Approximation only. Some reports may have incomplete information.
Do you take Meropenem and Abacavir?
- Personalize this study to your gender, age, symptoms and drugs
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, side effects of, and alternative drugs to the 2 drugs:
Browse all drug interactions of Meropenem and Abacavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zSub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Meropenem:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all side effects of Abacavir:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Meropenem and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all interactions between Abacavir and drugs from A to Z:
a b c d e f g h i j k l m n o p q r s t u v w x y zRelated publications that referenced our studies
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
- Erden M, Gulcan E, Bilen A, Bilen Y, Uyanik A, Keles M, "Pancytopen? a and Seps? s due to Meropenem: A Case Report", Tropical Journal of Pharmaceutical Research, 2013 Jan .
How the study uses the data?
The study uses data from the FDA. It is based on meropenem and abacavir sulfate (the active ingredients of Meropenem and Abacavir, respectively), and Meropenem and Abacavir (the brand names). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Ceftriaxone cause Anxiety Aggravated? - 2 seconds ago
- Could Guaifenesin cause Multiple Myeloma? - 3 seconds ago
- Could Humatrope cause Drug Ineffective? - 8 seconds ago
- Could Seroquel cause Aspartate Aminotransferase Increased? - 8 seconds ago
- Could Mucinex cause Joint Dislocation? - 21 seconds ago
- Could Gravol cause C-Reactive Protein Abnormal? - 25 seconds ago
- Teveten vs. Niaspan, side effect and effectiveness comparison - 32 seconds ago
- Could Wellbutrin Sr cause Sneezing? - 43 seconds ago
- Twynsta vs. Aldactone, side effect and effectiveness comparison - 44 seconds ago
- Colofac vs. Reglan, side effect and effectiveness comparison - 47 seconds ago